Skip to main content
Caplight Logo









Rithem Life Sciences

Rithem Life Sciences

Private
Wilmington, DelawareHealthcare & Life Scienceshttps://rithemls.com

Company Overview

Rithem Life Sciences operates in Healthcare & Life Sciences and is based in Wilmington, Delaware. It was founded in 2020.

Rithem Life Sciences is a medical device company that develops portable emergency cardiac-care products, including the ResQR CPR aid and the JoltzAED automated external defibrillator.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Home & Lifestyle

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Rithem Life Sciences Comparables

Compare Rithem Life Sciences with similar companies based on industry and business-model similarity.

Rithem Life Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rapid Response Revival Research Limited
88%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Rithem Life Sciences Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Rithem Life Sciences. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jonathan Rosenblum

Founder and CEO

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 73% MoM, from 1.2K to 2K.

  • Jan 21, 2026

    Monthly visitors grew 197% MoM, reaching 1.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Rithem Life Sciences Filings

Explore SEC and related filing metadata, where available.

Rithem Life Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Rithem Life Sciences's valuation, stock price, and market status.

Is Rithem Life Sciences a public or private company?

Rithem Life Sciences is a private company.

What is the current stock price of Rithem Life Sciences?

Rithem Life Sciences is a private company, so its shares have no public market price. Caplight tracks Rithem Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Rithem Life Sciences worth (valuation)?

Valuation information for Rithem Life Sciences is not publicly available.

Can I buy Rithem Life Sciences stock?

Rithem Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Rithem Life Sciences's last funding round?

Funding round information for Rithem Life Sciences is not publicly available.

Who are the main investors in Rithem Life Sciences?

Investor information for Rithem Life Sciences is not publicly disclosed.

Will Rithem Life Sciences IPO soon?

No public IPO plans have been announced for Rithem Life Sciences.

How can I track Rithem Life Sciences secondary market activity?

Caplight tracks bids, offers, and trades in Rithem Life Sciences's shares on secondary markets.

Firmographic Details

HeadquartersWilmington, Delaware
Employee Range7
Year Founded2020
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?